Tyrosine kinase inhibitors induce mitochondrial dysfunction during cardiomyocyte differentiation through alteration of GATA4-mediated networks

Abstract

SUMMARYMaternal drug exposure during pregnancy increases the risks of developmental cardiotoxicity, leading to congenital heart defects (CHDs). In this study, we used human stem cells as an in-vitro system to interrogate the mechanisms underlying drug-induced toxicity during cardiomyocyte differentiation, including anticancer tyrosine kinase inhibitor (TKI) drugs (imatinib, sunitinib, and vandetanib). H1-ESCs were treated with these drugs at sublethal levels during cardiomyocyte differentiation. We found that early exposure to TKIs during differentiation induced obvious toxic effects in differentiated cardiomyocytes, including disarranged sarcomere structure, interrupted Ca2+-handling, and impaired mitochondrial function. As sunitinib exposure showed the most significant developmental cardiotoxicity of all TKIs, we further examine its effect with in-vivo experiments. Maternal sunitinib exposure caused fetal death, bioaccumulation, and histopathologic changes in the neonatal mice. Integrative analysis of both transcriptomic and chromatin accessibility landscapes revealed that TKI-exposure altered GATA4-mediated regulatory network, which included key mitochondrial genes. Overexpression of GATA4 with CRISPR-activation restored morphologies, contraction, and mitochondria function in cardiomyocytes upon TKI exposure early during differentiation. Altogether, our study identified a novel crosstalk mechanism between GATA4 activity and mitochondrial function during cardiomyocyte differentiation, and revealed potential therapeutic approaches for reducing TKI-induced developmental cardiotoxicity for human health.HighlightsEarly-stage exposure to TKIs induced cardiotoxicity and mitochondrial dysfunctionGATA4 transcriptional activity is inhibited by TKIsNetwork analysis reveals interactions between GATA4 and mitochondrial genesGATA4-overexpression rescues cardiomyocytes and mitochondria from TKI exposure

Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes

“…Previous evidence indicates PGC-1α as a central regulator of cardiac metabolism and promoter of oxidative phosphorylation at the expense of glycolysis [77,78]. Whereas AMPK upregulation leads to improved mitochondrial activity and homeostasis in cardiomyocytes [79][80][81][82]. We found that AA-treated iPSC-CMs have undergone significant metabolic changes; genes responsible for the electron transport chain, oxidative phosphorylation, and fatty acid β-oxidation in mitochondria (NDUFV3, COX3, and COX5B) were highly expressed (Additional file 1: Fig.…”